Clinical trial
The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic…
NCT00247026 · Hadassah Medical Organization, Other · Withdrawn
Key facts
| NCT number | NCT00247026 |
|---|---|
| Title | The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes |
| Official title | A Pilot Study to Determine the Clinical Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Withdrawn |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndrome |
| Intervention type | Drug |
| Interventions | curcumin, coenzyme q10 |
| Enrollment | 50 |
| Start date | Apr 1, 2007 |
| First posted | Nov 1, 2005 |
| Last update posted | Apr 11, 2007 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: